Inogen (INGN) EBIT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 7.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 75.54% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -24.91% |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn | 24.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.76% |
| Dec 31, 2025 | 45.81% |
| Sep 30, 2025 | 11.57% |
| Jun 30, 2025 | -28.69% |
| Mar 31, 2025 | 17.40% |
| Dec 31, 2024 | -19.50% |
| Sep 30, 2024 | -47.71% |
| Jun 30, 2024 | -37.60% |
| Mar 31, 2024 | -96.90% |
| Dec 31, 2023 | -73.78% |
| Sep 30, 2023 | -187.16% |
| Jun 30, 2023 | -71.06% |
| Mar 31, 2023 | -115.85% |
| Dec 31, 2022 | -122.34% |
| Sep 30, 2022 | -48.42% |
| Jun 30, 2022 | -30.78% |
| Mar 31, 2022 | -68.65% |
| Dec 31, 2021 | -50.33% |
| Sep 30, 2021 | -15.05% |
| Jun 30, 2021 | -5.93% |
| Mar 31, 2021 | -30.94% |
| Dec 31, 2020 | -45.24% |
| Sep 30, 2020 | -30.78% |
| Jun 30, 2020 | -31.55% |
| Mar 31, 2020 | -33.72% |
| Dec 31, 2019 | -41.98% |
| Sep 30, 2019 | 14.53% |
| Jun 30, 2019 | 14.84% |
| Mar 31, 2019 | 14.02% |
| Dec 31, 2018 | 11.19% |
| Sep 30, 2018 | 40.93% |
| Jun 30, 2018 | 37.91% |
| Mar 31, 2018 | 51.18% |
| Dec 31, 2017 | 53.61% |
| Sep 30, 2017 | 32.68% |
| Jun 30, 2017 | 28.95% |
| Mar 31, 2017 | 53.21% |
| Dec 31, 2016 | 123.47% |
| Sep 30, 2016 | 82.63% |
| Jun 30, 2016 | 49.66% |
| Mar 31, 2016 | 72.99% |